Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oseltamivir Resistance in Influenza A/H1N1
NCT00949533Phase 3Completed
- Sponsor
- Roche
- Start
- Aug 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of oseltamivir in Influenza A (IAV) (2 arms), sponsored by Roche. Primary endpoint: Percentage of Participants Excreting Resistant Virus at Day 5. Started Aug 2009; status: completed.
02
Drugs
oseltamivir
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT00949533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00949533.